Laguitao, Jeannevive M.

HRN: 04-59-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2025
CEFUROXIME 1.5GM (VIAL)
08/16/2025
08/17/2025
IV
1.5gram
Post OR
S/P TAHRS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines